IMSIDOLIMAB

UNII:	KX89J0DFZ8
Formula:
Preferred Substance Name:	IMSIDOLIMAB
GSRS Full Record:	KX89J0DFZ8 i

2102543-86-0
ANB019
ANB-019
HUMANISED IGG4 KAPPA ANTI-HUMAN INTERLEUKIN 36 RECEPTOR ANB019
IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN INTERLEUKIN 36 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ANB019 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ANB019 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS INTERLEUKIN 36 RECEPTOR); HUMANIZED MUS MUSCULUS MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN (1-447) (HUMANIZED MUS MUSCULUS VH (HOMO SAPIENS IGHV1-46*01 (85%) (IGHD)-IGHJ4*01 (93%)) (8.8.13) (1-120)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(228))) (121-447)) (134-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HUMANIZED MUS MUSCULUS V-KAPPA (HOMO SAPIENS IGKV2D-29*01 (84%) IGKJ4*01)(11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (113'-219')), DIMER (226-226'':229-229'')-BISDISULFIDE
IMSIDOLIMAB [INN]
IMSIDOLIMAB [USAN]
IMSIDOLIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

IMSIDOLIMAB

Synonyms and Mappings

Resources